Related Experiment Video
Updated: May 1, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Cutoff serum pepsinogen values for predicting gastric acid secretion status
Katsunori Iijima1, Tomoyuki Koike, Yasuhiko Abe
1Division of Gastroenterology, Tohoku University Graduate School of medicine.
Serum pepsinogen levels can predict gastric acid secretion status, offering a less invasive method than traditional tests. This finding aids in assessing upper gastrointestinal disease risks.
Area of Science:
- Gastroenterology and Clinical Chemistry
Background:
- Gastric acid secretion measurement is crucial for upper gastrointestinal disease risk assessment but is invasive.
- Serum pepsinogen levels (pepsinogen I and II) reflect gastric function and may offer a less distressing alternative.
Purpose of the Study:
- To establish optimal serum pepsinogen cutoff points for predicting gastric acid secretion status (hypochlorhydria, hyperchlorhydria).
Main Methods:
- Correlated gastric acid secretion (endoscopic gastrin test) with serum pepsinogen I, pepsinogen II, pepsinogen I/II ratio, and Helicobacter pylori-IgG antibody in 627 Japanese subjects.
- Utilized receiver operating characteristic (ROC) analyses to determine the most accurate cutoff points.
Main Results:
- The pepsinogen I/II ratio correlated best with gastric acid secretion in H. pylori-positive subjects.
- Pepsinogen I showed the strongest correlation in H. pylori-negative subjects.
- Serum pepsinogen levels demonstrated acceptable to outstanding diagnostic accuracy (AUC: 0.79-0.93) for predicting gastric acid secretion status, with improved accuracy when stratified by H. pylori infection.
Conclusions:
- Serum pepsinogen I/II ratio (or pepsinogen I for H. pylori-negative individuals) is a valuable, non-invasive biomarker for assessing gastric acid secretion.
- This method has significant clinical implications for estimating upper gastrointestinal disease risks.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Gastric Phase of Digestion
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...

